Search

Your search keyword '"Mariusz Pytkowski"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Mariusz Pytkowski" Remove constraint Author: "Mariusz Pytkowski" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
44 results on '"Mariusz Pytkowski"'

Search Results

1. Should lethal arrhythmias in hypertrophic cardiomyopathy be predicted using non-electrophysiological methods?

2. The Comparative Effectiveness and Safety of Different Anticoagulation Strategies for Treatment of Left Atrial Appendage Thrombus in the Setting of Chronic Anticoagulation for Atrial Fibrillation or Flutter

Catalog

Books, media, physical & digital resources

4. Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry

5. A quality of life, clinical and biochemical improvements after catheter ablation of persistent arrhythmia in patients with structural heart disease and arrhythmia-mediated cardiomyopathy

8. Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review

9. Effectiveness and safety of a single freeze strategy of cryoballoon ablation of atrial fibrillation: an EHRA systematic review and meta-analysis

11. Rapid pharmacological cardioversion of recent-onset atrial fibrillation using antazoline in elderly patients

12. A novel ECG‐based algorithm to determine right ventricular lead placement in permanent pacemaker patients (RVpace study)

13. The long term risk of lead failure in patients with cardiovascular implantable electronic devices undergoing catheter ablation

14. Intravenous antazoline, a first‐generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio‐venous conduction and high clinical effectiveness (AntaEP Study)

15. Impact of body mass index on the outcome of catheter ablation of atrial fibrillation

16. Rhythm or rate control strategy in CRT recipients with long-standing persistent atrial fibrillation - preliminary results of the PilotCRAfT study

17. Utility of a novel 3F coronary sinus catheter during simultaneous ablation of the left anterolateral accessory pathway and left ventricular summit premature ventricular contractions

18. Identification of the ventricular tachycardia circuit using the Advisor HD Grid multielectrode mapping catheter

19. P1463Regional variation in survival rates among primary prevention implantable cardioverter-defibrillator recipients in Eastern and Northern Europe POLKARD Polish ICD Registry perspective

20. P1464A question of gender equality. Sex-related differences in survival after primary prevention implantable cardioverter-defibrillator implantation for dilated cardiomyopathy An analysis from POLKARD

21. P429The efficacy of electrical cardioversion of long-standing persistent or permanent atrial fibrillation in cardiac resynchronization therapy recipients

22. An unexpected outcome of successful radiofrequency ablation for persistent typical atrial flutter lasting 12 years

23. No benefits from exercise training and worse outcomes in heart failure patients with atrial fibrillation and cardiovascular implantable electronic devices

24. Clinical, echocardiographic, and pacing parameters affecting atrial fibrillation burden in patients with tachycardia-bradycardia syndrome

25. Leadless cardiac pacing as the important therapeutic option for the treatment of electrocardiotherapy complications

26. Correction to: The Comparative Effectiveness and Safety of Different Anticoagulation Strategies for Treatment of Left Atrial Appendage Thrombus in the Setting of Chronic Anticoagulation for Atrial Fibrillation or Flutter

27. A pacemaker-dependent patient undergoing high-dose stereotactic radiotherapy with the device located in the radiation area

28. P2878Higher all-cause mortality in patients with implanted dual-chamber cardioverter-defibrillators for secondary prevention: an analysis from the Polish ICD Registry

29. P990Assessment of clinical risk factors for all-cause mortality among hypertrophic cardiomyopathy patients with ICDs

30. Clinical factors affecting long term survival in patients with systolic heart failure and cardiac resynchronization therapy in advanced age

31. Comparative effectiveness and safety of antazoline‑based and propafenone‑based strategies for pharmacological cardioversion of short‑duration atrial fibrillation in the emergency department

32. New diagnostic pathways urgently needed. Protocol of PET Guidance I pilot study: positron emission tomography in suspected cardiac implantable electronic device-related infection

33. P6058No benefits of exercise training and worst possible outcomes for heart failure patients with atrial fibrillation and cardiac resynchronization therapy in 54 months follow-up

34. Every percent matters: pitfalls in the mapping and ablation of arrhythmogenic foci arising from the right coronary cusp or right ventricular outflow tract

36. P656Baseline cardiopulmonary exercise test result is the most useful parameter in predicting positive response and long-term survival after cardiac resynchronization therapy

37. P2697Utility of antazoline for cardioversion of recent onset atrial fibrillation in patients with a history of myocardial infarction

38. Efficacy and tolerability of mexiletine treatment in patients with recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator shocks

39. Long‐term risk of cardiovascular implantable electronic device–related infection after catheter ablation of arrhythmia

41. Clinical effectiveness and safety of antazoline‐based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short‐duration atrial fibrillation in the emergency department

42. P1451Clinical and pacing parameters related to atrial fibrillation in patients with tachycardia-bradycardia syndrome

43. P298Intravenous antazoline for cardioversion of recent onset atrial fibrillation in patients with stable coronary artery disease